DJ Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ slid 1.30% to $11.80 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.24% to 16,248.52 and the Dow Jones Industrial Average rising 0.80% to 38,904.04.
This was the stock's fifth consecutive day of losses.
Inovio Pharmaceuticals Inc. closed $2.95 below its 52-week high ($14.75), which the company achieved on April 1st.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.07% to $152.39, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.04% to $26.66.
Trading volume (233,855) remained 294,584 below its 50-day average volume of 528,439.
Data source: Dow Jones Market Data, FactSet. Data compiled April 5, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 05, 2024 17:30 ET (21:30 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments